1
|
Chow JJ, Leong KMW, Shun-Shin M, Jones S, Guttmann OP, Mohiddin SA, Lambiase P, Elliott PM, Ormerod JOM, Koa-Wing M, Lefroy D, Lim PB, Linton NWF, Ng FS, Qureshi NA, Whinnett ZI, Peters NS, Francis DP, Varnava AM, Kanagaratnam P. The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging. Front Physiol 2024; 15:1428709. [PMID: 39206383 PMCID: PMC11350108 DOI: 10.3389/fphys.2024.1428709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Accepted: 07/17/2024] [Indexed: 09/04/2024] Open
Abstract
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. Methods: HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts. Subjects underwent exercise testing by non-invasive electrocardiographic imaging to estimate epicardial electrophysiology. Results: Visual inspection of reconstructed epicardial HCM maps revealed isolated patches of late activation time (AT), prolonged activation-recovery intervals (ARIs), as well as reversal of apico-basal trends in T-wave inversion and ARI compared to controls (p < 0.005 for all). AT and ARI were compared between groups. The pooled HCM group had longer mean AT (60.1 ms vs. 52.2 ms, p < 0.001), activation dispersion (55.2 ms vs. 48.6 ms, p = 0.026), and mean ARI (227 ms vs. 217 ms, p = 0.016) than structurally normal heart controls. HCM ventricular arrhythmia survivors could be differentiated from HCM patients without a personal history of life-threatening arrhythmia by longer mean AT (63.2 ms vs. 57.4 ms, p = 0.007), steeper activation gradients (0.45 ms/mm vs. 0.36 ms/mm, p = 0.011), and longer mean ARI (234.0 ms vs. 221.4 ms, p = 0.026). A logistic regression model including whole heart mean activation time and activation recovery interval could identify ventricular arrhythmia survivors from the HCM cohort, producing a C statistic of 0.76 (95% confidence interval 0.72-0.81), with an optimal sensitivity of 78.6% and a specificity of 79.8%. Discussion: The HCM epicardial electrotype is characterized by delayed, dispersed conduction and prolonged, dispersed activation-recovery intervals. Combination of electrophysiologic measures with logistic regression can improve differentiation over single variables. Future studies could test such models prospectively for risk stratification of sudden death due to HCM.
Collapse
Affiliation(s)
- Ji-Jian Chow
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Kevin M. W. Leong
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Matthew Shun-Shin
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Sian Jones
- Cardiology Department, Imperial College Healthcare NHS Trust, London, United Kingdom
| | | | - Saidi A. Mohiddin
- Cardiology Department, Barts Heart Centre, London, United Kingdom
- Cardiology Department, Queen Mary, University of London, London, United Kingdom
| | - Pier Lambiase
- Cardiology Department, Barts Heart Centre, London, United Kingdom
| | - Perry M. Elliott
- Cardiology Department, Barts Heart Centre, London, United Kingdom
| | - Julian O. M. Ormerod
- Cardiology Department, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
| | - Michael Koa-Wing
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - David Lefroy
- Cardiology Department, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Phang Boon Lim
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | | | - Fu Siong Ng
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Norman A. Qureshi
- Cardiology Department, Imperial College Healthcare NHS Trust, London, United Kingdom
| | | | - Nicholas S. Peters
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Darrel P. Francis
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Amanda M. Varnava
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| | - Prapa Kanagaratnam
- National Heart and Lung Institute, Imperial College, London, United Kingdom
| |
Collapse
|
2
|
Pichara NL, Sacilotto L, Scanavacca MI, Cardoso AF, Soares BMAF, Falcochio PPPNF, Falcão AMG, Olivetti N, da Costa Darrieux FC, Chalela WA. Evaluation of a new treadmill exercise protocol to unmask type 1 Brugada electrocardiographic pattern: can we improve diagnostic yield? Europace 2023; 25:euad157. [PMID: 37410808 PMCID: PMC10325004 DOI: 10.1093/europace/euad157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Accepted: 05/10/2023] [Indexed: 07/08/2023] Open
Abstract
AIMS High precordial leads (HPL) on the resting electrocardiogram (ECG) are widely used to improve diagnostic detection of type 1 Brugada ECG pattern (Br1ECGp). A parasympathetic activation marks the initial recovery phase of treadmill stress testing (TET), and this can be useful for detecting the typical ECG pattern. Our study aimed to evaluate the role of a new HPL-treadmill exercise testing (TET) protocol in detecting Br1ECGp fluctuation compared to resting HPL-ECG. METHODS AND RESULTS 74 out of 163 patients of a Brugada syndrome (BrS) Brazilian cohort (GenBra Registry) underwent exercise testing with HPL-TET protocol. Precordial leads were displayed in strategic positions in the right and left parasternal spaces. The step-by-step analysis included ECG classification (as presence or absence of Br1ECGp) in standard vs. HPL leads placement in the following sequences: resting phase, maximal exercise, and the passive recovery phase (including 'quick lay down'). For heart rate recovery (HRR) measurements and comparisons, a Student's t-test was applied. McNemar tests compared the detection of Br1ECGp. The significance level was defined as P < 0.05. Fifty-seven patients (57/74; 77%) were male, the mean age was 49.0 ± 14, 78.4% had spontaneous BrS, and the mean Shanghai score was 4.5. The HPL-TET protocol increased Br1ECGp detection by 32.4% against resting HPL-ECG (52.7% vs. 20.3%, P = 0.001) alone. CONCLUSION Stress testing using HPL with the passive recovery phase in the supine position offers an opportunity to unmask the type 1 Br1ECGp, which could increase the diagnostic yield in this population.
Collapse
Affiliation(s)
- Nemer L Pichara
- Departament of Ergometry—Instituto do Coracao (Incor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| | - Luciana Sacilotto
- Arrhythmia Unit—Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Eneas de Carvalho Aguiar, 44 AB, CEP 05403-900 Sao Paulo, Brazil
| | - Maurício I Scanavacca
- Arrhythmia Unit—Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Eneas de Carvalho Aguiar, 44 AB, CEP 05403-900 Sao Paulo, Brazil
| | - Acácio Fernandes Cardoso
- Electrocardiology Service, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| | - Beatriz Moreira Ayub Ferreira Soares
- Departament of Ergometry—Instituto do Coracao (Incor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| | - Paola P PN F Falcochio
- Departament of Ergometry—Instituto do Coracao (Incor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| | - Andrea M G Falcão
- Departament of Ergometry—Instituto do Coracao (Incor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| | - Natalia Olivetti
- Laboratory of Genetics and Molecular Cardiology (LGMC) Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| | - Francisco Carlos da Costa Darrieux
- Arrhythmia Unit—Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Eneas de Carvalho Aguiar, 44 AB, CEP 05403-900 Sao Paulo, Brazil
| | - William A Chalela
- Departament of Ergometry—Instituto do Coracao (Incor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil - 05403-900
| |
Collapse
|
3
|
Leong KMW, Ng FS, Shun-Shin MJ, Koa-Wing M, Qureshi N, Whinnett ZI, Linton NF, Lefroy D, Francis DP, Harding SE, Davies DW, Peter NS, Lim PB, Behr E, Lambiase PD, Varnava A, Kanagaratnam P. Non-invasive detection of exercise-induced cardiac conduction abnormalities in sudden cardiac death survivors in the inherited cardiac conditions. Europace 2021; 23:305-312. [PMID: 33083839 DOI: 10.1093/europace/euaa248] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Accepted: 08/18/2020] [Indexed: 11/12/2022] Open
Abstract
AIMS Rate adaptation of the action potential ensures spatial heterogeneities in conduction across the myocardium are minimized at different heart rates providing a protective mechanism against ventricular fibrillation (VF) and sudden cardiac death (SCD), which can be quantified by the ventricular conduction stability (V-CoS) test previously described. We tested the hypothesis that patients with a history of aborted SCD due to an underlying channelopathy or cardiomyopathy have a reduced capacity to maintain uniform activation following exercise. METHODS AND RESULTS Sixty individuals, with (n = 28) and without (n = 32) previous aborted-SCD event underwent electro-cardiographic imaging recordings following exercise treadmill test. These included 25 Brugada syndrome, 13 hypertrophic cardiomyopathy, 12 idiopathic VF, and 10 healthy controls. Data were inputted into the V-CoS programme to calculate a V-CoS score that indicate the percentage of ventricle that showed no significant change in ventricular activation, with a lower score indicating the development of greater conduction heterogeneity. The SCD group, compared to those without, had a lower median (interquartile range) V-CoS score at peak exertion [92.8% (89.8-96.3%) vs. 97.3% (94.9-99.1%); P < 0.01] and 2 min into recovery [95.2% (91.1-97.2%) vs. 98.9% (96.9-99.5%); P < 0.01]. No significant difference was observable later into recovery at 5 or 10 min. Using the lowest median V-CoS scores obtained during the entire recovery period post-exertion, SCD survivors had a significantly lower score than those without for each of the different underlying aetiologies. CONCLUSION Data from this pilot study demonstrate the potential use of this technique in risk stratification for the inherited cardiac conditions.
Collapse
Affiliation(s)
- Kevin Ming Wei Leong
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Fu Siong Ng
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Matthew J Shun-Shin
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Michael Koa-Wing
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Norman Qureshi
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Zachary I Whinnett
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Nick F Linton
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - David Lefroy
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Darrel P Francis
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Sian E Harding
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - D Wyn Davies
- Imperial College Healthcare NHS Trust, London, UK
| | - Nicholas S Peter
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Phang Boon Lim
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Elijah Behr
- St George's University Hospitals NHS Trust, London, UK
| | | | - Amanda Varnava
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| | - Prapa Kanagaratnam
- Institute of Cardiovascular Science, University College London & Bart's Heart Centre, Bart's Health NHS Trust, London, UK.,Imperial College Healthcare NHS Trust, London, UK
| |
Collapse
|